We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Point-of-Care Capillary Whole Blood Hematocrit and Hemoglobin Compared

By LabMedica International staff writers
Posted on 14 Jun 2015
The clinical suitability of point-of-care devices for conductivity based point-of-care hematocrit with calculated hemoglobin necessitates that they be accurate and that the results are interchangeable with central laboratory methods.

The appropriateness of conductivity based assays in certain patient populations, such as patients on cardiopulmonary bypass and those receiving high volumes of intravenous fluids or autologous blood transfusions, has been questioned. More...


Clinical laboratory scientists at Massachusetts General Hospital (Boston, MA, USA) performed hematocrit and hemoglobin analysis on 225 clinical samples obtained from intensive care units and the cardiac surgery operating room. All samples were from adult patients over 18 years of age. The samples were first tested for clinical care and then immediately handed off to technologists for the study testing.

The total hemoglobin level was first measured by co-oximetry on the Siemens RAPIDLab 1265 analyzer (Siemens Medical Solutions USA, Inc.; Malvern, PA, USA). Hematocrit and hemoglobin values were obtained on the Abbott i-STAT instrument using one lot of i-STAT E3+ cartridges (Abbott Point of Care; Princeton, NJ, USA). Hemoglobin values from the i-STAT are performed by the calculation of directly measured hematocrit in percent × 0.34. A manual spun hematocrit was performed on each sample as the standard hematocrit reference method. The hematocrit and hemoglobin were also determined on the automated hematology analyzer XE5000 (Sysmex Corporation; Kobe, Japan) by impedance based cumulative pulse height detection and by photometric determination, respectively.

The i-STAT hematocrit and hemoglobin showed close agreement to comparison methods with minimal bias. Median test results were not clinically or statistically different between those measured on the i-STAT and those measured using the manual spun hematocrit reference method or the Sysmex photometric hemoglobin method. The results on the i-STAT were statistically significantly different from those obtained on the Sysmex for hematocrit and the Siemens RAPIDLab co-oximeter for hemoglobin.

The authors concluded that the i-STAT hematocrit and hemoglobin performs well when compared to the hematocrit reference method and other common methods for both hematocrit and hemoglobin. Some differences between non-reference methods may be observed, but these were not considered clinically significant. The study was published in the June 2015 issue of the journal Clinica Chimica Acta.

Related Links:

Massachusetts General Hospital 
Siemens Medical Solutions USA 
Abbott Point of Care 



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Automatic CLIA Analyzer
Shine i6000
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.